Interprofessional Care of Patients with Hemophilia

To participate in this activity, please:

Log in Sign Up

Advances in treatment have substantially extended the life expectancy of persons with hemophilia. At the same time, providing holistic patient-centered care has also grown more complex, necessitating that care is provided by an interprofessional, multidisciplinary team. The principles of interprofessional collaboration and real-world strategies for implementation in the care of patients with hemophilia are outlined.

Course Credit:

0.25 AAPA Category I CME Credit
0.25 ACPE Contact Hours
0.25 AMA PRA Category 1 CreditsTM
0.25 ANCC Contact Hours
0.25 CA-BRN Contact Hours

Dates:

Opens: 2025-10-31
Closes: 2026-10-31

Target Audience:

This activity was developed for nurse practitioners, pharmacists, physician associates, and physicians who provide care to patients with hemophilia.

This activity was self-funded by Annenberg Center for Health Sciences.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 hours AAPA Category 1 CME credits. Approval is valid until October 31, 2026. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 ANCC contact hours.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.25 contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Additional Content Planners

Melissa Ketchum, CHCP (Planner)
No significant relationships to disclose.

Madison Ragoonanan, PharmD, BCOP (Planner)
No significant relationships to disclose.

Sarah Rockwell, PharmD, BCOP (Planner)

Advisory Board: CTI Biopharma, Janssen

Consultant: Genentech


Gregory Scott, PharmD, RPh (Planner)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Contributing Faculty

  • Christopher Flores, MD

    Family Medicine Physician
    Eisenhower Medical Center
    Rancho Mirage, California

  • Craig M. Kessler, MD

    SOM Clinician Scholar Track – Professor
    Professor of Oncology
    Professor of Medicine and Pathology
    Director, Division of Coagulation, Department of Laboratory Medicine
    Director, Therapeutic and Cellular Apheresis Unit
    Director, Comprehensive Hemophilia and Thrombophilia Treatment Center
    Georgetown University Medical Center
    Washington, DC

  • LaTosha Mollette, DNP

    Family Nurse Practitioner
    Louisiana Family Medicine Clinic
    Jonesboro, Louisiana

  • Michael Smith, PharmD

    Clinical Pharmacist in Pain/Palliative Care
    University of Michigan
    Ann Arbor, Michigan

  • Guy Young, MD

    Director, Hemostasis and Thrombosis Center
    Director, Clinical Coagulation Laboratory
    Cancer and Blood Disorders Institute
    Children's Hospital Los Angeles
    Professor of Pediatrics
    University of Southern California Keck School of Medicine
    Los Angeles, California

Learning Objectives

  • Describe the evolution in the treatment landscape for patients with hemophilia.
  • Identify strategies to improve interprofessional, multidisciplinary care of patients with hemophilia.

Faculty Disclosures

Christopher Flores, MD

No relationships to disclose.

Craig M. Kessler, MD

Advisory Board: BioMarin, CSL Behring, Genentech, Novo Nordisk, Regeneron, Sanofi, Takeda

Data Monitoring Safety Board: Bayer, Octapharma


LaTosha Mollette, DNP

No relationships to disclose.

Michael Smith, PharmD

No relationships to disclose.

Guy Young, MD

Consultant: BioMarin, CSL Behring, Genentech/Roche, HEMA Biologics, Novo Nordisk, Octapharma, Pfizer, Sanofi, Takeda